Epic Gold reports 440,000-ounce inferred gold resource at Hawkins project in Ontario
Bitget2026/10/08 11:31Epic Gold reported an NI 43-101 inferred resource of 440,400 oz gold at the Hawkins Gold Project in Ontario. Estimate totals 14,016,000 tonnes grading 0.98 g/t Au, split between pit-constrained and out-of-pit underground components. Pit-constrained portion: 360,000 oz from 12,645,000 tonnes at 0.89 g/t, using a 0.24 g/t cut-off. Underground portion: 80,400 oz from 1,371,000 tonnes at 1.82 g/t, using a 1.2 g/t cut-off. Assumptions include US$ 3,500/oz gold price and 93% recovery; effective date Sept. 11, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Epic Gold Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610080730NEWSFILECNPR____20261008_318018_1) on October 08, 2026, and is solely responsible for the information contained therein.
- Epic Gold reported an NI 43-101 inferred resource of 440,400 oz gold at the Hawkins Gold Project in Ontario.
- Estimate totals 14,016,000 tonnes grading 0.98 g/t Au, split between pit-constrained and out-of-pit underground components.
- Pit-constrained portion: 360,000 oz from 12,645,000 tonnes at 0.89 g/t, using a 0.24 g/t cut-off.
- Underground portion: 80,400 oz from 1,371,000 tonnes at 1.82 g/t, using a 1.2 g/t cut-off.
- Assumptions include US$ 3,500/oz gold price and 93% recovery; effective date Sept. 11, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
